PMC:7589163 / 88136-88402 JSONTXT

{"project":"LitCovid-PD-UBERON","denotations":[{"id":"T179","span":{"begin":39,"end":45},"obj":"Body_part"}],"attributes":[{"id":"A179","pred":"uberon_id","subj":"T179","obj":"http://purl.obolibrary.org/obo/UBERON_0016552"}],"text":"At 1 month: shorter duration of cough, phlegm, and wheezing, respectively (p \u003c 0.001). At 3 months: 14% less time ill (p \u003c 0.0001). At 6 months: shorter duration of fever, nasal secretion, difficulty breathing, rash, and “other illness,” respectively (all p \u003c 0.05)."}

{"project":"LitCovid-PD-CLO","denotations":[{"id":"T787","span":{"begin":0,"end":4},"obj":"http://purl.obolibrary.org/obo/CLO_0001757"}],"text":"At 1 month: shorter duration of cough, phlegm, and wheezing, respectively (p \u003c 0.001). At 3 months: 14% less time ill (p \u003c 0.0001). At 6 months: shorter duration of fever, nasal secretion, difficulty breathing, rash, and “other illness,” respectively (all p \u003c 0.05)."}

{"project":"LitCovid-PD-GO-BP","denotations":[{"id":"T168","span":{"begin":178,"end":187},"obj":"http://purl.obolibrary.org/obo/GO_0046903"},{"id":"T169","span":{"begin":200,"end":209},"obj":"http://purl.obolibrary.org/obo/GO_0007585"}],"text":"At 1 month: shorter duration of cough, phlegm, and wheezing, respectively (p \u003c 0.001). At 3 months: 14% less time ill (p \u003c 0.0001). At 6 months: shorter duration of fever, nasal secretion, difficulty breathing, rash, and “other illness,” respectively (all p \u003c 0.05)."}

{"project":"LitCovid-PD-HP","denotations":[{"id":"T261","span":{"begin":32,"end":37},"obj":"Phenotype"},{"id":"T262","span":{"begin":51,"end":59},"obj":"Phenotype"},{"id":"T263","span":{"begin":165,"end":170},"obj":"Phenotype"},{"id":"T264","span":{"begin":189,"end":209},"obj":"Phenotype"},{"id":"T265","span":{"begin":211,"end":215},"obj":"Phenotype"}],"attributes":[{"id":"A261","pred":"hp_id","subj":"T261","obj":"http://purl.obolibrary.org/obo/HP_0012735"},{"id":"A262","pred":"hp_id","subj":"T262","obj":"http://purl.obolibrary.org/obo/HP_0030828"},{"id":"A263","pred":"hp_id","subj":"T263","obj":"http://purl.obolibrary.org/obo/HP_0001945"},{"id":"A264","pred":"hp_id","subj":"T264","obj":"http://purl.obolibrary.org/obo/HP_0002098"},{"id":"A265","pred":"hp_id","subj":"T265","obj":"http://purl.obolibrary.org/obo/HP_0000988"}],"text":"At 1 month: shorter duration of cough, phlegm, and wheezing, respectively (p \u003c 0.001). At 3 months: 14% less time ill (p \u003c 0.0001). At 6 months: shorter duration of fever, nasal secretion, difficulty breathing, rash, and “other illness,” respectively (all p \u003c 0.05)."}

{"project":"LitCovid-sentences","denotations":[{"id":"T581","span":{"begin":87,"end":99},"obj":"Sentence"},{"id":"T582","span":{"begin":100,"end":131},"obj":"Sentence"},{"id":"T583","span":{"begin":132,"end":266},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"text":"At 1 month: shorter duration of cough, phlegm, and wheezing, respectively (p \u003c 0.001). At 3 months: 14% less time ill (p \u003c 0.0001). At 6 months: shorter duration of fever, nasal secretion, difficulty breathing, rash, and “other illness,” respectively (all p \u003c 0.05)."}

{"project":"LitCovid-PubTator","denotations":[{"id":"3632","span":{"begin":32,"end":37},"obj":"Disease"},{"id":"3633","span":{"begin":165,"end":170},"obj":"Disease"},{"id":"3634","span":{"begin":211,"end":215},"obj":"Disease"}],"attributes":[{"id":"A3632","pred":"tao:has_database_id","subj":"3632","obj":"MESH:D003371"},{"id":"A3633","pred":"tao:has_database_id","subj":"3633","obj":"MESH:D005334"},{"id":"A3634","pred":"tao:has_database_id","subj":"3634","obj":"MESH:D005076"}],"namespaces":[{"prefix":"Tax","uri":"https://www.ncbi.nlm.nih.gov/taxonomy/"},{"prefix":"MESH","uri":"https://id.nlm.nih.gov/mesh/"},{"prefix":"Gene","uri":"https://www.ncbi.nlm.nih.gov/gene/"},{"prefix":"CVCL","uri":"https://web.expasy.org/cellosaurus/CVCL_"}],"text":"At 1 month: shorter duration of cough, phlegm, and wheezing, respectively (p \u003c 0.001). At 3 months: 14% less time ill (p \u003c 0.0001). At 6 months: shorter duration of fever, nasal secretion, difficulty breathing, rash, and “other illness,” respectively (all p \u003c 0.05)."}